High-growth drug companies Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
23:46
Jun 18
Jun 18
Health insurers and high-growth drugs win.
Healthcare is a polarized sector. He likes the health insurers and the highest growth drug companies, but not much else in between.
MED
About High-growth drug companies Investor Commentary
Across the available history and selected sources, Buzzberg tracks High-growth drug companies across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Jim Cramer.